FR2359607B1 - - Google Patents

Info

Publication number
FR2359607B1
FR2359607B1 FR7723022A FR7723022A FR2359607B1 FR 2359607 B1 FR2359607 B1 FR 2359607B1 FR 7723022 A FR7723022 A FR 7723022A FR 7723022 A FR7723022 A FR 7723022A FR 2359607 B1 FR2359607 B1 FR 2359607B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7723022A
Other languages
French (fr)
Other versions
FR2359607A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2359607A1 publication Critical patent/FR2359607A1/fr
Application granted granted Critical
Publication of FR2359607B1 publication Critical patent/FR2359607B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7723022A 1976-07-27 1977-07-27 Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active Granted FR2359607A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH958876 1976-07-27

Publications (2)

Publication Number Publication Date
FR2359607A1 FR2359607A1 (fr) 1978-02-24
FR2359607B1 true FR2359607B1 (da) 1980-02-22

Family

ID=4353539

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7723022A Granted FR2359607A1 (fr) 1976-07-27 1977-07-27 Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active

Country Status (27)

Country Link
JP (1) JPS5315411A (da)
AR (1) AR216479A1 (da)
AT (1) AT369987B (da)
AU (1) AU515738B2 (da)
BE (1) BE857122A (da)
CA (1) CA1095833A (da)
CY (1) CY1261A (da)
DE (1) DE2732335C2 (da)
DK (1) DK325677A (da)
ES (1) ES461020A1 (da)
FI (1) FI772217A (da)
FR (1) FR2359607A1 (da)
GB (1) GB1589982A (da)
GR (1) GR65014B (da)
HK (1) HK81884A (da)
HU (1) HU178340B (da)
IE (1) IE45534B1 (da)
IL (1) IL52587A (da)
KE (1) KE3441A (da)
MY (1) MY8400057A (da)
NL (1) NL176227C (da)
NO (1) NO149874C (da)
NZ (1) NZ184722A (da)
PT (1) PT66850B (da)
SE (1) SE437469B (da)
SG (1) SG53884G (da)
ZA (1) ZA774536B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS61254522A (ja) * 1985-05-02 1986-11-12 Takada Seiyaku Kk 錠剤組成物
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
GB1301849A (da) * 1969-12-15 1973-01-04
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions

Also Published As

Publication number Publication date
ES461020A1 (es) 1979-05-01
KE3441A (en) 1984-09-14
GR65014B (en) 1980-06-13
JPS5315411A (en) 1978-02-13
DK325877A (da) 1978-01-20
AU2730177A (en) 1979-02-01
NL176227B (nl) 1984-10-16
AT369987B (de) 1983-02-25
IE45534B1 (en) 1982-09-22
AR216479A1 (es) 1979-12-28
DE2732335C2 (de) 1983-01-20
GB1589982A (en) 1981-05-20
CA1095833A (en) 1981-02-17
IL52587A (en) 1980-09-16
MY8400057A (en) 1984-12-31
SE7708265L (sv) 1978-01-28
HU178340B (en) 1982-04-28
IE45534L (en) 1978-01-27
NL176227C (nl) 1985-03-18
DK325677A (da) 1978-01-28
NO149874C (no) 1984-07-11
BE857122A (fr) 1978-01-25
PT66850A (fr) 1977-08-01
DE2732335A1 (de) 1978-02-02
AU515738B2 (en) 1981-04-30
CY1261A (en) 1984-11-23
PT66850B (fr) 1979-03-13
FR2359607A1 (fr) 1978-02-24
JPS5726650B2 (da) 1982-06-05
FI772217A (da) 1978-01-28
ATA541377A (de) 1982-07-15
SG53884G (en) 1985-03-08
IL52587A0 (en) 1977-10-31
NO149874B (no) 1984-04-02
ZA774536B (en) 1979-02-28
NZ184722A (en) 1980-10-24
NO772575L (no) 1978-01-30
HK81884A (en) 1984-11-25
NL7708162A (nl) 1978-01-31
SE437469B (sv) 1985-03-04

Similar Documents

Publication Publication Date Title
FR2356753B3 (da)
FR2362589B1 (da)
FR2359607B1 (da)
FR2375987B2 (da)
FR2375371B1 (da)
FR2355338B1 (da)
JPS5652659Y2 (da)
JPS5373080U (da)
JPS52127703U (da)
JPS532083U (da)
JPS562149Y2 (da)
JPS5616362Y2 (da)
JPS52108058U (da)
CS175510B1 (da)
CS177776B1 (da)
JPS52169583U (da)
JPS52118538U (da)
JPS5344985U (da)
JPS5341694U (da)
JPS5338048U (da)
CS177789B1 (da)
JPS52112897U (da)
CS178345B1 (da)
CH598942A5 (da)
DD124441A1 (da)

Legal Events

Date Code Title Description
ST Notification of lapse